|
Index of reports
> Cases with Lung Infection (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Pulmozyme (Dornase Alfa) where reactions include lung infection. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Pulmozyme side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient: male
Reactions: Lung Infection
Drug(s) suspected as cause:
Pulmozyme
Possible Pulmozyme side effects in female
Reported by a physician from Romania on 2011-11-01
Patient: female, weighing 18.0 kg (39.6 pounds)
Reactions: Pneumonia, Increased Upper Airway Secretion, Pseudomonas Infection, Lung Infection, Pyrexia, Blood Fibrinogen Increased, Pulmonary Function Test Decreased, Disease Progression, Leukocytosis, RED Blood Cell Sedimentation Rate Increased, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acetylcysteine
Dosage: unk
Pulmozyme
Dosage: unk
Placebo
Dosage: placebo
Indication: Cystic Fibrosis
Start date: 2010-10-08
Pulmozyme
Dosage: 25 mg, unk
Start date: 2006-06-03
Other drugs received by patient: Ventolin; Albuterol; Azithromycin; Acetylcysteine; Creon
|
